The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML

Acute myeloid leukemia (AML) is a genetically heterogeneous disease with a clinical course predicted by recurrent cytogenetic abnormalities and/or gene mutations. The NPM1 insertion mutations define the largest distinct genetic subset, ∼30% of AML, and is considered a favorable risk marker if there...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunlap, Jennifer B., Leonard, Jessica, Rosenberg, Mara, Cook, Rachel, Press, Richard, Fan, Guang, Raess, Philipp W., Druker, Brian J., Traer, Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771683/
https://www.ncbi.nlm.nih.gov/pubmed/31145495
http://dx.doi.org/10.1002/ajh.25517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771683/
https://www.ncbi.nlm.nih.gov/pubmed/31145495
http://dx.doi.org/10.1002/ajh.25517

Ejemplares similares